-
Posted by
Two Blokes Jun 24 -
Filed in
Stock
-
3 views
AstraZeneca said on Tuesday that U.S. regulators have approved its precision drug Datroway to treat a type of lung cancer, adding that the drugmaker would now pay partner Daiichi Sankyo $45 million in milestone-related considerations.
